Treatment Evolution after COPD Diagnosis in the UK Primary Care Setting
Open Access
- 2 September 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (9), e105296
- https://doi.org/10.1371/journal.pone.0105296
Abstract
To assess the treatment progression during the 24 months following a formal diagnosis of chronic obstructive pulmonary disease (COPD) in the UK primary care setting. A retrospective cohort of newly diagnosed COPD patients was identified in the Clinical Practice Research Datalink (CPRD) from 1/1/2008 until 31/12/2009. Maintenance therapy prescribed within the first 3 months of diagnosis and in the subsequent 3-month intervals for 24 months were analyzed. Treatment classes included long-acting β2-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), inhaled corticosteroids (ICSs), and respective combinations. At each 3-month interval, discontinuation, switching, addition, and stepping down patterns were analyzed cumulatively for the first 12 months and over the 24-month of follow-up. A total of 3199 patients with at least one prescription of a maintenance therapy at baseline and during 4th-6th month interval were included in the analysis. At diagnosis (0–3 months), the most frequently prescribed maintenance therapy was LABA+ICS (43%), followed by LAMA (24%) and LABA+LAMA+ICS (23%). Nearly half the patients (LABA-50%, LAMA-43%) starting on a monobronchodilator had additions to their treatment in 24 months. Compared to other medications, patients starting on a LAMA were most likely to escalate to triple therapy in 24 months. Nearly one-fourth of the patients prescribed triple therapy at baseline stepped down to LABA+ICS (25%) or LAMA (31%) within 24 months. Disease progression is evident over the 24 months after COPD diagnosis, as more patients were prescribed additional maintenance therapy in the 24-month period compared to baseline. The changes in therapy suggest that it is difficult to achieve a consistently improved COPD disease state.Keywords
This publication has 12 references indexed in Scilit:
- Chronic obstructive pulmonary disease – a treatable diseaseSwiss Medical Weekly, 2013
- The role of bronchodilator treatment in the prevention of exacerbations of COPDEuropean Respiratory Journal, 2012
- Barriers to adherence to COPD guidelines among primary care providersRespiratory Medicine, 2012
- Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomesPrimary Care Respiratory Journal, 2012
- Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physiciansInternational Journal of Chronic Obstructive Pulmonary Disease, 2011
- General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort StudySwiss Medical Weekly, 2010
- Adaptation and validation of the Charlson Index for Read/OXMIS coded databasesBMC Family Practice, 2010
- Treatment persistence and compliance with medications for chronic obstructive pulmonary diseaseCanadian Respiratory Journal, 2007
- International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Chronic Obstructive Pulmonary Disease (COPD)Primary Care Respiratory Journal, 2006
- Inspiratory Capacity, Dynamic Hyperinflation, Breathlessness, and Exercise Performance during the 6-Minute-Walk Test in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001